Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 3

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3CNS 3

Conditions

Oligodendroglioma 3Gliosarcoma 3Glioblastoma 3Central Nervous System Neoplasms 3Brain Neoplasms 3Astrocytoma 3Glioma 1

Interventions

Temozolomide 45Radiotherapy 20Filgrastim 17Carmustine 15Carboplatin 15Irinotecan 13Bevacizumab 13Magnetic Resonance Spectroscopy 12Surgical Procedures, Operative 11Peripheral Blood Stem Cell Transplantation 9Erlotinib Hydrochloride 9sargramostim 8O(6)-benzylguanine 8Radiation 7Topotecan 6Thiotepa 6Radiotherapy, Intensity-Modulated 6Procarbazine 6Etoposide 6Drug Therapy 6Cyclophosphamide 6Chemotherapy, Adjuvant 6aldesleukin 5Vorinostat 5Sirolimus 5Imatinib Mesylate 5Granulocyte Colony-Stimulating Factor 5Busulfan 52-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 5temsirolimus 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Astrocytoma × Iodine-125 × Sarcoma × Clear all
NCT00003876 2013-06-26

Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma

National Cancer Institute (NCI)

Phase 1 Completed
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00003574 2013-06-21

Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors

National Cancer Institute (NCI)

Phase 2 Completed
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00045474 2009-02-09

Brachytherapy in Treating Patients With Recurrent Malignant Glioma

National Cancer Institute (NCI)

Phase 1 Completed
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡